PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF DYSLIPIDEMIA ACCOMPANIED BY HIGH BLOOD PRESSURE

摘要

The invention relates to the pharmaceutical industry in general and to the pharmaceutical industry involved in the production of drugs for controlling dyslipidemias accompanied by high arterial blood pressure with an elevated risk of cerebrovascular and cardiovascular thromboembolic ischemic events. More specifically, the invention relates to a composition formed by a HMG-CoA reductase-inhibiting substance known as rosuvastatin calcium, combined with a calcium channel-inhibiting antihypertensive known as amlodipine besylate and a platelet antiaggregate known as acetylsalicylic acid, which produce a product having a synergic effect with smaller delivery doses and lower risks of adverse events.